| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Developmental Anatomy, University of California School of Medicine, San Francisco, California 94143-0738
Address all correspondence to: Dr. Barbara A. Foster, Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030. E-mail: grcunha{at}itsa.ucsf.edu
The studies presented herein quantitated ductal branching morphogenesis
in the anterior prostate (AP) of the newborn rat. Four parameters were
measured: epithelial area, epithelial perimeter, node number, and form
factor. Nine natural and synthetic androgens were tested for their
effectiveness in inducing postnatal prostatic development using 808
newborn rat APs in 68 dose-response experiments. Based on these studies
it was shown that testosterone (T) was slightly more effective than
dihydrotestosterone (DHT) in supporting ductal branching morphogenesis
in the developing rat AP. Furthermore, the activity of T could not be
accounted for simply by conversion of T to DHT. Synthetic androgens,
7
-methyl-19-nortestosterone and methyltrienolone (R1881), which
cannot be 5
-reduced to DHT, also induced extensive ductal branching
and elicited responses less than those to T and not statistically
different from those to DHT. This suggests that although DHT is
sufficient for prostatic development, it is not necessary for postnatal
ductal branching morphogenesis and growth of the prostate.
5
-Androstan-3
,17ß-diol was particularly potent in inducing
ductal branching, eliciting a response greater than or comparable to
those of T and DHT. Androsterone, androstanedione,
5
-androstan-3ß,17ß-diol and 5ß-androstan-3
,17ß-diol
induced ductal branching, but to a lesser extent than either T or DHT.
These studies challenge the assumption that DHT is essential for
prostatic development, specifically during ductal branching
morphogenesis of the neonatal rat prostate.
This article has been cited by other articles:
![]() |
S. Feng, Q. Tang, M. Sun, J. Y. Chun, C. P. Evans, and A. C. Gao Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2 Mol. Cancer Ther., March 1, 2009; 8(3): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-j. Shao, H. Y. Shi, G. Ayala, D. Rowley, and M. Zhang Haploinsufficiency of the Maspin Tumor Suppressor Gene Leads to Hyperplastic Lesions in Prostate Cancer Res., July 1, 2008; 68(13): 5143 - 5151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O von Bueren, R. Ma, M. Schlumpf, and W. Lichtensteiger Salbutamol exhibits androgenic activity in vitro Br. J. Sports Med., December 1, 2007; 41(12): 874 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ma, B. Cotton, W. Lichtensteiger, and M. Schlumpf UV Filters with Antagonistic Action at Androgen Receptors in the MDA-kb2 Cell Transcriptional-Activation Assay Toxicol. Sci., July 1, 2003; 74(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Lee, W. Lou, M. Hou, F. de Miguel, L. Gerber, and A. C. Gao Interleukin-6 Promotes Androgen-independent Growth in LNCaP Human Prostate Cancer Cells Clin. Cancer Res., January 1, 2003; 9(1): 370 - 376. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |